Valuation: Becton, Dickinson and Company

Market Cap 5.1TCr 4.56TCr 4.25TCr 3.85TCr 7.25TCr 4,84500Cr 7.31TCr 51TCr 20TCr 2,52000Cr 19TCr 19TCr 8,08500Cr P/E 2026 *
36.1x
P/E 2027 * 20.1x
Enterprise Value 6.69TCr 5.98TCr 5.57TCr 5.05TCr 9.51TCr 6,35200Cr 9.58TCr 67TCr 26TCr 3,30400Cr 25TCr 25TCr 10,60100Cr EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.29x
Free-Float
73.18%
Yield 2026 *
2.09%
Yield 2027 * 2.13%
1 day-0.80%
1 week+3.92%
Current month+4.68%
1 month+5.35%
3 months+21.80%
6 months+20.55%
Current year-3.45%
1 week 178.9
Extreme 178.9
189.99
1 month 175.71
Extreme 175.71
189.99
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
262.23
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
28/09/26 Sell

Executive/Senior Manager

-76 0.0000%
02/09/26 Tax

Chief Financial Officer

-190 0.0001%
26/08/26 Sell

Executive/Senior Manager

-165 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%+3.92%+0.38%-27.57% 5.1TCr
+0.78%+4.53%-21.90%+12.92% 18TCr
+1.17%+6.80%-2.69%+29.25% 12TCr
-0.02%+1.56%-22.57%+9.57% 11TCr
-0.31%-0.27%-46.72%-10.85% 7.53TCr
+1.55%+4.34%+4.14%+74.68% 6.3TCr
+0.12%+0.80%+19.45%+66.57% 5.35TCr
-0.69%+0.95%-17.84%+22.09% 4.1TCr
-1.00%+2.00%+30.46%+11.64% 3.21TCr
-0.17%+0.42% - - 3.13TCr
Average +0.06%+2.32%-6.37%+20.92% 7.52TCr
Weighted average by Cap. +0.33%+3.04%-11.94%+19.60%

Financials

2026 *2027 *
Net sales 1.93TCr 1.72TCr 1.61TCr 1.46TCr 2.74TCr 1,83000Cr 2.76TCr 19TCr 7.53TCr 95TCr 7.24TCr 7.08TCr 3,05400Cr 1.97TCr 1.76TCr 1.64TCr 1.49TCr 2.8TCr 1,87400Cr 2.83TCr 20TCr 7.71TCr 97TCr 7.41TCr 7.25TCr 3,12700Cr
Net income 143.66Cr 128.33Cr 119.62Cr 108.45Cr 204.09Cr 14TCr 205.7Cr 1.43TCr 560.96Cr 7.09TCr 539.54Cr 527.7Cr 23TCr 233.95Cr 208.99Cr 194.79Cr 176.6Cr 332.36Cr 22TCr 334.97Cr 2.33TCr 913.51Cr 12TCr 878.62Cr 859.35Cr 37TCr
Net Debt 1.59TCr 1.42TCr 1.32TCr 1.2TCr 2.26TCr 1,50800Cr 2.27TCr 16TCr 6.2TCr 78TCr 5.97TCr 5.83TCr 2,51600Cr 1.4TCr 1.25TCr 1.16TCr 1.05TCr 1.98TCr 1,32400Cr 2TCr 14TCr 5.45TCr 69TCr 5.24TCr 5.12TCr 2,21000Cr
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
13/26/13 $187.37 -0.80% 11,53,001
12/26/12 $188.89 +2.80% 11,84,422
09/26/09 $183.75 +0.55% 16,15,714
08/26/08 $182.75 +1.44% 15,23,705
07/26/07 $180.16 -0.08% 19,22,325
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
187.37USD
Average target price
194.08USD
Spread / Average Target
+3.58%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company